IDEAYA Biosciences $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by IDEAYA Biosciences, Inc. of its common stock for up to an aggregate amount of $250 million. The common stock is listed on the Nasdaq Global Select Market under the symbol “IDYA.”
Based in South San Francisco, California, IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Jonathan Bye and Jennifer Chung. All members of the Davis Polk team are based in the Northern California office.